Publications

Summer 2005

TWO STUDIES FROM THE DEPARTMENT OF OBSTETRICS AND GYNECOLOGY SEEK PARTICIPANTS

Study to prevent preterm delivery
Saint Barnabas Medical Center is the only hospital in New Jersey and one of only 15 hospitals nationally to be chosen for inclusion in a clinical trial aimed at preventing preterm delivery through the administration of vaginal progesterone. Leon Smith, Jr., M.D., Director of the Division of Maternal-Fetal Medicine at Saint Barnabas, is chief investigator; Veronica Ravnikar, M.D., Chair of the Department of Obstetrics and Gynecology, is co-investigator.

In this Phase III randomized study, women who have a history of spontaneous preterm delivery will have either Prochieve® 8%, a progesterone gel, or a placebo placed in their cervix. Prochieve 8% delivers progesterone vaginally in an easy-to-use pre-filled, tampon-like applicator, and the product does not restrict normal activities. The treatment is given on a weekly basis to women whose last pregnancy resulted in a preterm birth at 35 weeks or less. Women interested in participating in the PROTERM study should contact The Division of Maternal-Fetal Medicine at (973) 322- 5287.

Study to treat patients with Overactive Bladder (OAB)
The Center for Urogynecology of Saint Barnabas is one of only 40 sites nationally to participate in a new clinical trial to access the effectiveness of a new delivery method of an approved medication for overactive bladder. In the clinical trial, patients will be given oxybutynin, a medication used for more than 30 years to treat this condition. The study will assess a new delivery method of this already approved drug.

Overactive bladder involves a need to get to the bathroom quickly to avoid an accident. In addition to feelings of urgency, the condition is usually accompanied by frequent urination, even at night. About forty percent of people with this condition experience wetting accidents.

If you are a woman with overactive bladder or incontinence you may qualify for the new research study. Women who qualify to participate will receive all study-related care at no charge, including physician visits, study medication, and lab services. Compensation of $500 a participant is offered.

Qualified women must:

• Be diagnosed over six months ago with overactive bladder or incontinence
• Have a history of urine leakage
• Have sudden and frequent urges to urinate
• Be in general good health
  

For more information call, please call The Center for Urogynecology at (973) 322-9998.

[ top ] [ back to index ]